{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:12:21Z","timestamp":1761959541772,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T00:00:00Z","timestamp":1410825600000},"content-version":"vor","delay-in-days":258,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1016\/j.lrr.2014.09.001","type":"journal-article","created":{"date-parts":[[2014,10,27]],"date-time":"2014-10-27T21:38:42Z","timestamp":1414445922000},"page":"90-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Successful HLA haploidentical myeloablative stem cell transplantation for aggressive hepatosplenic alpha\/beta (\u03b1\u03b2) T-cell lymphoma"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1743-9525","authenticated-orcid":false,"given":"Gioacchino","family":"Catania","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Zallio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Monaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Corsetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicol","family":"Trincheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Bonello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lia","family":"Mele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Dallavalle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia","family":"Salvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Pini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lrr.2014.09.001_bib1","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/sj.leu.2401784","article-title":"Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990","volume":"14","author":"Weidmann","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.lrr.2014.09.001_bib2","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2003-05-1675","article-title":"Hepatosplenic \u03b3\u03b4 T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients","volume":"102","author":"Belhadj","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2014.09.001_bib3","first-page":"109","article-title":"Successful treatment of hepatosplenic T-cell lymphoma with ESHAP followed by autologous stem cell transplant","volume":"11","author":"Chalmers","year":"2013","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.lrr.2014.09.001_bib4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.clml.2012.09.002","article-title":"Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience","volume":"13","author":"Voss","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.lrr.2014.09.001_bib5","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/leu.2011.240","article-title":"Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed\/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect","volume":"26","author":"Dodero","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.lrr.2014.09.001_bib6","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1080\/10428190601126941","article-title":"Allogeneic stem cell transplantation for hepatosplenic gammadelta T-cell lymphoma","volume":"48","author":"Konuma","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.lrr.2014.09.001_bib7","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/annonc\/mdn751","article-title":"Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment","volume":"20","author":"Falchook","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lrr.2014.09.001_bib8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/sj.bmt.1705272","article-title":"Long-term remission in a patient with hepatosplenic gammadelta T cell lymphoma after cord blood stem cell transplantation following autologous peripheral blood stem cell transplantation","volume":"37","author":"Sakai","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.lrr.2014.09.001_bib9","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the Biomed-2 Concerted Action BMH4-CT98-3936","author":"Van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.lrr.2014.09.001_bib10","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/cncr.21150","article-title":"Hyperfractionated cyclophosphamide with high-doses of arabinosylcytosine and methotrexate (HyperCHiDAM Verona 897)","volume":"104","author":"Todeschini","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.lrr.2014.09.001_bib11","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.leu.2404306","article-title":"Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation","volume":"20","author":"Corradini","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.lrr.2014.09.001_bib12","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1200\/JCO.2011.40.2719","article-title":"Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01","volume":"30","author":"d\u2019Amore","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lrr.2014.09.001_bib13","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0140-6736(83)91793-2","article-title":"Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia","volume":"1","author":"Powles","year":"1983","journal-title":"Lancet"},{"issue":"84","key":"10.1016\/j.lrr.2014.09.001_bib14","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1182\/blood.V84.11.3948.bloodjournal84113948","article-title":"Successful engraftment of T-cell-depleted haploidentical \u201cthree-loci\u201d incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum","volume":"1","author":"Aversa","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2014.09.001_bib15","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1053\/j.seminoncol.2012.09.005","article-title":"Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation","volume":"39","author":"Luznik","year":"2012","journal-title":"Semin Oncol"},{"key":"10.1016\/j.lrr.2014.09.001_bib16","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbmt.2013.01.006","article-title":"Outcomes of related donor HLA-identical or HLA-haploidentical allogeneic blood or marrow transplantation for peripheral T cell lymphoma","volume":"19","author":"Kanakry","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"31","key":"10.1016\/j.lrr.2014.09.001_bib17","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.2012.44.3523","article-title":"T cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosfamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplant","volume":"1","author":"Bashey","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lrr.2014.09.001_bib18","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.bbmt.2012.06.019","article-title":"Haploidentical transplantation using T cell replete peripheral blood stem cells and myeloablative conditioning in patients with high risk hematologic malignancies who lack conventional donors in well tolerated and produces excellent relapse-free survival","volume":"18","author":"Solomon","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.lrr.2014.09.001_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbmt.2012.08.014","article-title":"Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning","volume":"19","author":"Raiola","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"26","key":"10.1016\/j.lrr.2014.09.001_bib20","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1200\/JCO.2007.14.1366","article-title":"Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Soci\u00e9t\u00e9 Francaise de Greffe de Mo\u00eblle et de Th\u00e9rapie Cellulaire","volume":"10","author":"Le Gouill","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lrr.2014.09.001_bib21","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/sj.bmt.1700989","article-title":"Allogeneic bone marrow transplantation in patients who relapse after autologous transplantation","volume":"20","author":"Tsai","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.lrr.2014.09.001_bib22","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1080\/10428190701400071","article-title":"Graft-versus-lymphoma effect in progressive hepatosplenic gamma\/delta T-cell lymphoma","volume":"48","author":"He","year":"2007","journal-title":"Leuk Lymphoma"}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048914000193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048914000193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:07:36Z","timestamp":1761959256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048914000193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"alternative-id":["S2213048914000193"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2014.09.001","relation":{},"ISSN":["2213-0489"],"issn-type":[{"type":"print","value":"2213-0489"}],"subject":[],"published":{"date-parts":[[2014]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful HLA haploidentical myeloablative stem cell transplantation for aggressive hepatosplenic alpha\/beta (\u03b1\u03b2) T-cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2014.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}